<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>primedex_10qa1-073103.txt
<TEXT>
<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON D.C. 20549

                                    FORM 10-Q
                                 AMENDMENT NO. 1

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the quarterly period ended   July 31, 2003


                                       or

[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the transition period from  ______________________  to  ____________________

Commission File Number   0-19019


                          PRIMEDEX HEALTH SYSTEMS, INC.
--------------------------------------------------------------------------------
               (Exact name of registrant as specified in charter)

New York                                                              13-3326724
--------------------------------------------------------------------------------
(State or other jurisdiction                (I.R.S. Employer Identification No.)
of incorporation or organization)

1510 Cotner Avenue                                Los Angeles, California  90025
--------------------------------------------------------------------------------
(Address of principal executive offices)                              (Zip Code)

(310) 478-7808
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)

n/a
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 of 15(d) of the Securities and Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
                                                                  Yes [X] No [ ]

     Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Exchange Act).

                                                                  Yes [ ] No [X]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                  PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

     Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 and 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court.
                                                                  Yes [X] No [ ]


                                       1
<PAGE>


PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
PART II - OTHER INFORMATION
--------------------------------------------------------------------------------

    ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

          a) Exhibit 32.1 - Certification


                                   SIGNATURE


                                   Primedex Health Systems, Inc.
                                   (Registrant)


October 3, 2003                    By: Howard G. Berger, M.D.
                                       -----------------------------------------
                                       Howard G. Berger, M.D., President,
                                       Treasurer and Principal Financial Officer


                                       2

</TEXT>
</DOCUMENT>